Jim Simons’s Recursion Pharmaceuticals RXRX Stock Holding History

Jim Simons’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.37M	Buy	+2,400,605	New	+$9.28M	0.01%	1147
2023 Q3	–	Sell	-350,000	Closed	-$2.62M	–	4041
2023 Q2	$2.62M	Sell	350,000 -65,561	-16%	-$459K	﹤0.01%	1829
2023 Q1	$2.77M	Buy	415,561 +221,661	+114%	+$1.76M	﹤0.01%	1823
2022 Q4	$1.5M	Buy	193,900 +178,700	+1,176%	+$1.75M	﹤0.01%	2266
2022 Q3	$162K	Sell	15,200 -246,400	-94%	-$2.5M	﹤0.01%	3447
2022 Q2	$2.13M	Buy	261,600 +83,200	+47%	+$557K	﹤0.01%	2140
2022 Q1	$1.28M	Buy	+178,400	New	+$1.9M	﹤0.01%	2564

Other funds holding RXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jim Simons's RXRX Position: Q1 2026 in Review

Jim Simons opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 2,400,605 shares worth $7.37M. The stake represents 0.01% of the portfolio and ranks #1147 among its holdings. This is a return to the name: Jim Simons previously reported a position in RXRX as recently as Q2 2023.

Jim Simons first reported a position in RXRX in Q1 2022 and has held it in 7 quarters since. 335 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

Jim Simons held 2,400,605 shares of Recursion Pharmaceuticals worth $7.37M as of Q1 2026.
Recursion Pharmaceuticals was a new Jim Simons position in Q1 2026.
Recursion Pharmaceuticals made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1147 holding.
Jim Simons first reported a position in Recursion Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
335 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.